Robert J Linhardt Selected Research

Viral Zoonoses

11/2021

Implications of Glycosaminoglycans on Viral Zoonotic Diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert J Linhardt Research Topics

Disease

38	Neoplasms (Cancer) 01/2022 - 10/2002
17	Infections 01/2022 - 10/2003
13	Inflammation (Inflammations) 04/2021 - 01/2007
10	Hemorrhage 01/2021 - 03/2010
9	Thrombocytopenia (Thrombopenia) 09/2021 - 09/2008
8	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 06/2002
8	Lung Neoplasms (Lung Cancer) 11/2021 - 03/2010
8	Neoplasm Metastasis (Metastasis) 11/2021 - 06/2012
8	Pathologic Processes 04/2021 - 09/2004
8	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2004
7	Thrombosis (Thrombus) 09/2021 - 05/2006
6	COVID-19 11/2021 - 01/2020
5	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2021 - 01/2020
5	Sepsis (Septicemia) 11/2019 - 03/2014
4	Venous Thrombosis (Deep-Vein Thrombosis) 09/2021 - 01/2003
4	Hypoxia (Hypoxemia) 01/2020 - 03/2011
3	Mucopolysaccharidoses 10/2022 - 06/2015
3	Myocardial Infarction 01/2022 - 01/2013
3	Osteoarthritis 05/2021 - 02/2010
3	Disease Progression 01/2021 - 02/2012
3	Communicable Diseases (Infectious Diseases) 01/2021 - 11/2013
3	Colonic Neoplasms (Colon Cancer) 04/2020 - 04/2014
3	Lyme Disease (Disease, Lyme) 01/2020 - 12/2017
3	Lung Injury 11/2019 - 03/2014
3	Hypotension (Low Blood Pressure) 10/2019 - 03/2009
3	Arthritis (Polyarthritis) 12/2017 - 01/2015
3	Malaria 02/2014 - 10/2003
3	Breast Neoplasms (Breast Cancer) 03/2012 - 03/2010
2	Type 2 Diabetes Mellitus (MODY) 06/2022 - 02/2020
2	Stroke (Strokes) 01/2022 - 12/2020
2	Hyperglycemia 01/2022 - 01/2020
2	Bacterial Infections (Bacterial Infection) 01/2021 - 07/2014
2	Obesity 08/2020 - 11/2006
2	Endotoxemia 07/2020 - 01/2019
2	Hypertrophy 02/2020 - 11/2018
2	Metabolic Diseases (Metabolic Disease) 02/2020 - 06/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2019 - 10/2018
2	Dysbiosis 03/2019 - 10/2018
2	Wounds and Injuries (Trauma) 01/2019 - 03/2014
2	Septic Shock (Toxic Shock Syndrome) 01/2019 - 01/2016
2	Venous Thromboembolism 01/2019 - 09/2017
2	Cognitive Dysfunction 01/2019 - 11/2018
2	Osteoporosis 01/2019 - 11/2018
2	Cerebrospinal Fluid Leak 01/2019 - 10/2015

Drug/Important Bio-Agent (IBA)

37	Heparin (Liquaemin)FDA LinkGeneric 06/2022 - 01/2003
33	GlycosaminoglycansIBA 10/2022 - 03/2003
25	Heparitin Sulfate (Heparan Sulfate)IBA 10/2022 - 09/2002
20	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2003
19	Polysaccharides (Glycans)IBA 06/2022 - 12/2004
15	AnticoagulantsIBA 01/2021 - 01/2003
10	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2022 - 08/2009
8	DisaccharidesIBA 01/2020 - 04/2007
7	AntibodiesIBA 09/2021 - 11/2006
7	OligosaccharidesIBA 04/2021 - 01/2007
7	Proteoglycans (Proteoglycan)IBA 12/2020 - 01/2007
6	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 10/2013
5	EnzymesIBA 01/2022 - 10/2010
5	Glycoproteins (Glycoprotein)IBA 05/2021 - 11/2006
5	Carrier Proteins (Binding Protein)IBA 01/2021 - 01/2005
5	CarbohydratesIBA 07/2020 - 01/2005
5	Biological ProductsIBA 05/2020 - 11/2006
5	Pharmaceutical PreparationsIBA 01/2020 - 08/2009
5	LigandsIBA 01/2017 - 01/2004
4	VaccinesIBA 09/2021 - 06/2015
4	Biomarkers (Surrogate Marker)IBA 02/2020 - 03/2014
4	Dermatan SulfateIBA 10/2017 - 10/2013
4	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 12/2011 - 10/2003
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 01/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2014
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2021 - 01/2004
3	Platelet Factor 4IBA 09/2021 - 06/2017
3	Peptides (Polypeptides)IBA 01/2021 - 01/2018
3	GlycolipidsIBA 01/2021 - 04/2014
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2020 - 04/2015
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 07/2019 - 03/2010
3	Antineoplastic Agents (Antineoplastics)IBA 04/2019 - 07/2016
3	Syndecan-1 (Syndecan 1)IBA 10/2017 - 04/2014
3	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 03/2011 - 01/2004
3	CarrageenanIBA 10/2010 - 04/2008
3	acharan sulfateIBA 08/2010 - 03/2003
2	CathepsinsIBA 10/2022 - 02/2021
2	Hormones (Hormone)IBA 01/2022 - 11/2018
2	Retinaldehyde (Retinal)IBA 01/2022 - 01/2019
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022 - 11/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 07/2008
2	Amyloid (Amyloid Fibrils)IBA 10/2021 - 09/2014
2	PrebioticsIBA 10/2021 - 04/2020
2	fucoidanIBA 02/2021 - 10/2018
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2021 - 09/2018
2	Angiotensin-Converting Enzyme 2IBA 01/2021 - 11/2020
2	Immunoglobulin G (IgG)IBA 11/2020 - 01/2020
2	LipopolysaccharidesIBA 07/2020 - 11/2019
2	AntioxidantsIBA 05/2020 - 07/2019
2	PhycocyaninIBA 04/2020 - 04/2019
2	Phosphotransferases (Kinase)IBA 01/2020 - 03/2010
2	akebia saponin DIBA 01/2019 - 11/2018
2	Transferrin (beta 2 Transferrin)IBA 01/2019 - 10/2015
2	Antiviral Agents (Antivirals)IBA 01/2019 - 11/2006

Therapy/Procedure

13	Therapeutics 06/2022 - 03/2010
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2019 - 09/2017